Navigating MS and Cancer Treatments

This chapter explores the effects of immune checkpoint inhibitors on multiple sclerosis (MS) patients receiving cancer treatment. It highlights findings from a study of 18 patients, revealing a low risk of relapse and the importance of tailored approaches in managing therapies. The discussion emphasizes the need for collaboration between neurologists and oncologists to optimize patient care while navigating the complexities of both conditions.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app